ACH
ArrowMark Colorado Holdings’s 4D Molecular Therapeutics FDMT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.91M | Sell |
514,614
-12,656
| -2% | -$47K | 0.03% | 231 |
|
|
2025
Q1 | $1.7M | Sell |
527,270
-267,328
| -34% | -$863K | 0.03% | 233 |
|
|
2024
Q4 | $4.43M | Sell |
794,598
-8,892
| -1% | -$49.5K | 0.06% | 199 |
|
|
2024
Q3 | $8.69M | Sell |
803,490
-46,711
| -5% | -$505K | 0.11% | 151 |
|
|
2024
Q2 | $17.8M | Sell |
850,201
-228,124
| -21% | -$4.79M | 0.21% | 97 |
|
|
2024
Q1 | $34.4M | Sell |
1,078,325
-123,115
| -10% | -$3.92M | 0.39% | 71 |
|
|
2023
Q4 | $24.3M | Buy |
1,201,440
+116,719
| +11% | +$2.36M | 0.27% | 91 |
|
|
2023
Q3 | $13.8M | Buy |
1,084,721
+53,323
| +5% | +$679K | 0.17% | 112 |
|
|
2023
Q2 | $18.6M | Sell |
1,031,398
-1,321
| -0.1% | -$23.9K | 0.2% | 101 |
|
|
2023
Q1 | $17.8M | Buy |
1,032,719
+50,520
| +5% | +$868K | 0.2% | 102 |
|
|
2022
Q4 | $21.8M | Sell |
982,199
-547,759
| -36% | -$12.2M | 0.26% | 88 |
|
|
2022
Q3 | $12.3M | Buy |
1,529,958
+105,644
| +7% | +$849K | 0.15% | 127 |
|
|
2022
Q2 | $9.94M | Buy |
1,424,314
+278,729
| +24% | +$1.95M | 0.11% | 161 |
|
|
2022
Q1 | $17.3M | Buy |
1,145,585
+34,006
| +3% | +$514K | 0.15% | 130 |
|
|
2021
Q4 | $24.4M | Buy |
1,111,579
+108,132
| +11% | +$2.37M | 0.2% | 110 |
|
|
2021
Q3 | $27.1M | Sell |
1,003,447
-26,450
| -3% | -$713K | 0.21% | 112 |
|
|
2021
Q2 | $24.8M | Sell |
1,029,897
-18,292
| -2% | -$440K | 0.19% | 118 |
|
|
2021
Q1 | $45.5M | Sell |
1,048,189
-15,555
| -1% | -$675K | 0.34% | 80 |
|
|
2020
Q4 | $44.1M | Buy |
+1,063,744
| New | +$44.1M | 0.34% | 84 |
|